A 15-minute video call after surgery may stop chronic pain in opioid users

NCT ID NCT07717151

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This trial tests whether a specialized teleconsultation 2-4 weeks after surgery can prevent chronic postsurgical pain in people who already use opioids. Participants are randomly assigned to standard follow-up or standard follow-up plus a teleconsultation to detect poorly controlled pain, nerve pain, or opioid-related issues and adjust treatment. The study tracks pain, opioid use, and quality of life for 6 months, with the main result at 3 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
specialized teleconsultation between postoperative day 15-28 to detect and manage pain and opioid concerns
What this could lead to
If effective, this teleconsultation could become a simple, scalable way to prevent chronic pain and reduce long-term opioid use in high-risk surgical patients.
What could go wrong
This is a single trial with 354 participants, and the benefit may depend on how well patients and doctors follow the teleconsultation recommendations. Results may not apply to all types of surgery or opioid users.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OPIOID USERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU Amiens-Picardie

    RECRUITING

    Amiens, 80054, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.